SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently trending following reports of a joint acquisition offer from Stripe and Advent International at a premium, fueling significant community debate over whether the bid represents a fair valuation or an opportunistic lowball offer. Investors are actively discussing the potential for a bidding war, management's response to the proposal, and whether the stock's long-term turnaround strategy warrants a significantly higher price.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing intense selling pressure as investors weigh concerns over high debt levels, credit rating headwinds, and the scalability of AI data center capital expenditures. While some market participants see a contrarian buying opportunity at these support levels, others are actively betting on further downside, pointing to a lack of clear communication from leadership to stabilize sentiment.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending following its largest single-day percentage decline in history after issuing a preliminary earnings warning, where management cited a structural shift in enterprise spending toward AI hardware like servers and memory at the expense of traditional software. While many investors are panic-selling and speculating on further downside, a significant portion of the community views the crash as an extreme market overreaction, actively positioning themselves for a bounce by highlighting the company's long-term quantum computing potential and defensive dividend profile.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML Holding NV is trending due to heightened investor focus on the long-term AI infrastructure cycle and semiconductor capital expenditure, with the community actively monitoring company leadership commentary regarding supply-constrained markets and strategic equipment demand. Analysts are currently debating the stock's valuation premium and potential growth trajectories, as conversations remain polarized between profit-taking behavior and bullish long-term sentiment regarding the firm's monopoly position in EUV lithography.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is trending as investors aggressively position themselves ahead of the upcoming earnings release, which is viewed as a definitive demand signal for the broader semiconductor and AI hardware sector. Market participants are actively debating the impact of ongoing geopolitical risks versus the company's sustained foundry dominance, with significant activity noted in both bullish call options and recent institutional accumulation.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar Automotive Holding UK PLC

Polestar is currently trending as the community debates its strategic shift toward European growth and the recent launch of new model variants while navigating challenges in the U.S. market. Investors are closely monitoring upcoming strategic updates and the company's long-term path to profitability amidst heavy competition in the global EV sector.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing significant volatility and intense community focus as traders react to a massive 20-for-1 forward stock split alongside a sharp, liquidity-driven correction in the South Korean market. Retail investors are debating the sustainability of the recent KOSPI rebound, with many weighing the risks of leverage-fueled liquidations against the long-term growth potential of the semiconductor and memory sectors.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific (BSX) is trending as investors debate whether the stock represents a deep-value opportunity after a significant downturn or a potential value trap. The community is actively discussing the company's valuation relative to peers, management's communication strategy, and whether recent institutional buying and share repurchase programs indicate a long-term bottom.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix shares are experiencing intense volatility and heavy retail interest following its recent U.S. ADR debut, with the community actively debating whether the stock is a long-term AI infrastructure winner or currently overvalued compared to its Korean listing. Traders remain divided as they monitor the interplay between the Nasdaq ticker, the underlying Korean market, and the recent introduction of leveraged ETFs, all while navigating broader concerns about chip sector cyclicality.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is trending as traders navigate a scheduled 1-for-10 reverse stock split and elevated market volatility driven by semiconductor sector earnings and geopolitical tensions. The community is actively debating the merits of holding the leveraged inverse fund during the transition, with many traders focusing on aggressive scalping strategies and speculating on potential price pivots following the reverse split.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Neurocrine (NBIX) Run Higher on Rising Earnings Estimates?

Neurocrine Biosciences (NBIX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus

DGX's Q2 results may reflect growth across physician, hospital and consumer channels as AI tools and advanced diagnostics gain traction.

GSK's Jemperli Delivers Promising Interim Data in Rectal Cancer

GSK reports positive interim phase II AZUR-1 data as Jemperli meets the primary endpoint in rectal cancer, supporting potential regulatory filings.

CG Oncology Stock Gains 12% in Three Months: What's Driving It?

CGON climbs as cretostimogene nears a planned 2026 BLA filing, posts encouraging phase II data. It maintains a cash position that supports operations through 2029.

3 Reasons Why Growth Investors Shouldn't Overlook Neurocrine (NBIX)

Neurocrine (NBIX) possesses solid growth attributes, which could help it handily outperform the market.

Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results

Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results Neurocrine Biosciences Announces Conference Call and Webcast of Second Quarter 2026 Financial Results PR Newswire SAN DIEGO, July 9, 2026 Conference Call and Webcast Scheduled for Thursday, July...

United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know

UTHR's strong clinical wins for Tyvaso and ralinepag, along with progress in organ manufacturing, are boosting growth prospects despite rising PAH competition.

Agilent Strengthens Biopharma Growth Prospects With AI Expansion

A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.


Neurocrine (NBIX) Upgraded to Strong Buy: What Does It Mean for the Stock?

Neurocrine (NBIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

VRTX to Strengthen Rare Disease Portfolio With $10B Crinetics Buyout 

Vertex to acquire CRNX for $10B, adding approved rare disease drug Palsonify and late-stage pipeline assets to expand its endocrinology portfolio.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

Neurocrine-Soleno Deal Garners Wall Street Praise — Analyst Applauds Business Development Acumen

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$172.04
Prev Close	$174.10
Open	$177.33
Dividend Yield	0.00%
50-Day Moving Average	$160.65
Beta	0.74
Avg. Volume	1.23M
PE Ratio	26.45

52-Week High	$181.18
52-Week Low	$122.14
Market Capitalization	$17.51B
EPS (Annual)	$4.67
Price to Book	5.08
Revenue Per Employee	$1.43M

Feed

News

Sentiment

Earnings

Fundamentals

Info

NBIXNeurocrine Biosciences, Inc.

Latest NBIX News